
"This finding can help countries make informed decisions regarding vaccine policy -- for instance, whether those previously infected should be vaccinated in priority and, if so, with how many doses," said Professor Michael Edelstein, from Bar-Ilan University, who led the study.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OMjc7H
via
IFTTT
0 comments:
Post a Comment